Literature DB >> 11015314

Effects of (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), sigma (sigma) ligands, on micturition in anaesthetized rats.

I Shimizu1, K Kawashima, D Ishii, M Oka.   

Abstract

The effects of two sigma (sigma) binding site ligands, (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), on bladder functions were examined in rats. Cystometry using urethane-anaesthetized rats showed that (+)-pentazocine (1 - 5 mg kg(-1), i.v.) and DTG (1 - 5 mg kg(-1), i.v.) prolonged micturition intervals, indicating increased bladder capacity and raised the threshold pressure. The effects of (+)-pentazocine (2 mg kg(-1), i.v. ) on micturition were not influenced by naloxone (0.5 mg kg(-1), i.v. ), which antagonized similar effects of morphine (2 mg kg(-1), i.v.). When administered intracerebroventricularly (i.c.v.), DTG (1 microg) and (+)-pentazocine (30 microg) prolonged micturition intervals with increased threshold pressure on the cystometrogram. In isolated bladder detrusor strips of rats, (+)-pentazocine (3 microM) and DTG (1 microM) did not affect contractile responses to electrical field stimulation. A higher concentration of DTG (3 microM) slightly suppressed the response induced by 30 Hz stimulation. The effects of (+)-pentazocine and DTG on micturition were abolished by pre-treatment with pertussis toxin (PTX, 1 microg, i.c.v.). These results indicate that typical sigma ligands, such as (+)-pentazocine and DTG, increase bladder capacity in anaesthetized rats. Moreover, the mechanism by which sigma ligands change the urinary storage properties in rats may involve pathways in which the function of Gi/o proteins is necessary.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015314      PMCID: PMC1572351          DOI: 10.1038/sj.bjp.0703593

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

3.  Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.

Authors:  T P Su
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

4.  Urodynamics in acetone-induced cystitis of anesthetized rats.

Authors:  I Shimizu; K Kawashima; K Hosoki
Journal:  Neurourol Urodyn       Date:  1999       Impact factor: 2.696

5.  [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].

Authors:  N N Samovilova; K N Iarygin; V A Vinogradov
Journal:  Bioorg Khim       Date:  1985-10

6.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

7.  Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary.

Authors:  S A Wolfe; S G Culp; E B De Souza
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

8.  Sigma receptors regulate contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin.

Authors:  B G Campbell; M W Scherz; J F Keana; E Weber
Journal:  J Neurosci       Date:  1989-10       Impact factor: 6.167

9.  Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.

Authors:  S W Tam; L Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

10.  Correlation of inhibitory potencies of putative antagonists for sigma receptors in brain and spleen.

Authors:  T P Su; S E Schell; F Y Ford-Rice; E D London
Journal:  Eur J Pharmacol       Date:  1988-04-13       Impact factor: 4.432

View more
  6 in total

Review 1.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder.

Authors:  Nicola A Colabufo; Francesco Berardi; Marialessandra Contino; Roberto Perrone; Vincenzo Tortorella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-17       Impact factor: 3.000

3.  SYA 013 analogs as moderately selective sigma-2 (σ2) ligands: Structure-affinity relationship studies.

Authors:  Lamya Al-Ghanim; Xue Y Zhu; Gladys Asong; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2019-01-31       Impact factor: 3.641

4.  Inflammation-induced enhancement of the visceromotor reflex to urinary bladder distention: modulation by endogenous opioids and the effects of early-in-life experience with bladder inflammation.

Authors:  Jennifer DeBerry; Timothy J Ness; Meredith T Robbins; Alan Randich
Journal:  J Pain       Date:  2007-08-20       Impact factor: 5.820

5.  Actions of tramadol on micturition in awake, freely moving rats.

Authors:  Raj Kumar Pandita; Rikard Pehrson; Thomas Christoph; Elmar Friderichs; Karl-Erik Andersson
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

6.  Synaptic connections between endomorphin 2-immunoreactive terminals and μ-opioid receptor-expressing neurons in the sacral parasympathetic nucleus of the rat.

Authors:  Xiao Liang Dou; Rong Liang Qin; Juan Qu; Yong Hui Liao; Ya cheng Lu; Ting Zhang; Chen Shao; Yun Qing Li
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.